SCHEMBL2529186

SCHEMBL2529186

COC(=O)CCCCCCC(=O)C(C(=O)c1ccc(OC)cc1)c1ccncc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 2/20 0.41
▸ HDAC1 Q13547 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ NAMPT P43490 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ BCHE P06276 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ CYP17A1 P05093 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2528789 0.82 HDAC8 (0.45) HDAC8HDAC1MEN1KMT2ALMNA
SCHEMBL3939697 0.75 SMN1; SMN2 (0.46) MEN1KMT2ALMNAALDH1A1SMN1; SMN2
SCHEMBL7385100 0.73 SMN1; SMN2 (0.53) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL2527207 0.73 L3MBTL1 (0.41) HDAC8HDAC1KMT2ALMNAALDH1A1
SCHEMBL6160043 0.72 HDAC8 (0.72) HDAC8HDAC1KMT2ANPC1RAB9A
SCHEMBL12217089 0.72 SMN1; SMN2 (0.43) MEN1KMT2ALMNASMN1; SMN2NAMPT
SCHEMBL5856026 0.71 CYP1A2 (0.53) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL12087551 0.71 CYP1A2 (0.49) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL5215589 0.70 CES2 (0.57) MEN1KMT2ANPC1RAB9APOLB
Hydrochloric Acid SCHEMBL11482394 0.70 CYP1A2 (0.51) MEN1KMT2ANPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039634-B2 Oxazole hydroxamic acid derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-10-18 — — US disclosed
US-20090209596-A1 Oxazole Hydroxamic Acid Derivatives and Use Thereof SK HOLDINGS CO., LTD 2009-08-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209596-A1 Oxazole Hydroxamic Acid Derivatives and Use Thereof HDAC1, HDAC5, HDAC7 HDAC8 9/4885HDAC1 1/4885MEN1 3549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback